MUSTANG BIO, INC. Increase (Decrease) in Prepaid Expense
MUSTANG BIO, INC. (MBIO) reported Increase (Decrease) in Prepaid Expense of $278.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-29.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2018-03-29
- MUSTANG BIO, INC. increase (decrease) in prepaid expense for the quarter ending 2017-12-31 was -$136.00K.
- MUSTANG BIO, INC. increase (decrease) in prepaid expense for the quarter ending 2017-09-30 was $406.00K.
- MUSTANG BIO, INC. increase (decrease) in prepaid expense for the quarter ending 2017-06-30 was -$7.00K.
- MUSTANG BIO, INC. increase (decrease) in prepaid expense for the quarter ending 2017-03-31 was $15.00K.
- MUSTANG BIO, INC. increase (decrease) in prepaid expense for fiscal 2017 was $278.00K.
- MUSTANG BIO, INC. increase (decrease) in prepaid expense for fiscal 2016 was $0.00.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 9 month | Increase (Decrease) in Prepaid Expense 10 month | Increase (Decrease) in Prepaid Expense 12 month |
|---|---|---|---|---|---|
| 2017-12-31 | -$136.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $270.00K derived: sum of 2 quarters · filed 2018-03-29 | $263.00K derived: sum of 3 quarters · filed 2018-03-29 | $278.00K 10-K · filed 2018-03-29 | |
| 2017-09-30 | $406.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $399.00K derived: sum of 2 quarters · filed 2017-11-14 | $414.00K 10-Q · filed 2017-11-14 | $414.00K derived: sum of 4 quarters · filed 2018-03-29 | |
| 2017-06-30 | -$7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $8.00K 10-Q · filed 2017-08-14 | $8.00K derived: sum of 3 quarters · filed 2018-03-29 | $8.00K derived: sum of 4 quarters · filed 2018-03-29 | |
| 2017-03-31 | $15.00K 10-Q · filed 2017-05-15 | $15.00K derived: sum of 2 quarters · filed 2018-03-29 | $15.00K derived: sum of 3 quarters · filed 2018-03-29 | $15.00K derived: sum of 4 quarters · filed 2018-03-29 | |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $0.00 derived: sum of 2 quarters · filed 2018-03-29 | $0.00 derived: sum of 3 quarters · filed 2018-03-29 | $0.00 10-K · filed 2018-03-29 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $0.00 derived: sum of 2 quarters · filed 2017-11-14 | $0.00 10-Q · filed 2017-11-14 | ||
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $0.00 10-Q · filed 2017-08-14 | |||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-15 | ||||
| 2015-12-31 | $0.00 10-K · filed 2018-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |